Antibiotic can protect the heart New Study Shows.

Antibiotic can protect the heart New Study Shows, Virginia Commonwealth University researchers studying rapamycin, an antibiotic used to increase organ survival in transplant patients, found that the drug is to protect the heart against tissue injury following acute myocardial infarction.

Rapamycin blocks protein synthesis by inhibiting the mammalian target of rapamycin , an essential component in the way of cell cycle progression, the drug has been found that important in transplantation, especially in kidney or heart transplant addition being Kukreja because of that. Antibiotic properties of the anti – growth, rapamycin effectively reduces coronary restonosis, the abnormal narrowing of a blood vessel in coronary stents are implanted coated with rapamycin, reduce the risk of restonosis.

Detected in the July issue the Journal of Molecular and Cellular Cardiology, the official publication of the International Society for Heart Research, researchers for the first time that pretreatment with a clinically relevant dose of rapamycin protective effect against protective effect against heart attack injury and reduced programmed cell death.ADXS11-001 a therapeutic vaccine, different the currently marketed prophylactic vaccines, the women who have Already a dealt with due as a result of human papillomavirus infection, which most common sexually transmitted sickness in the U.S. Today. Advaxis did been tabled file an IND causing a Phase II study HPV cervical intraepithelial neoplasia , which has pre-cancerous. Advaxis.

Advaxis ‘proprietary fusion protein of which possibility to generate a robust immune response, cancel immune tolerance towards Crab and generate an exceptionally powerful and effective multi-level therapeutic immune response group consisting cancers and other disorders.. For further about the company is available at:via the ADXS11-001 ImmunotherapyAdvaxis ‘ technology platform uses modified Listeria monocytogenes for deliver a tumor of specific antigen The fusion protein separate Preclinical, biotechnology weakened Listeria.